Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial
在既往未接受过甲氨蝶呤治疗或接受过甲氨蝶呤治疗的活动性类风湿关节炎患者中,菲戈替尼联合甲氨蝶呤或单药治疗与甲氨蝶呤单药治疗的疗效比较:FINCH 3 期随机对照试验
期刊:Annals of the Rheumatic Diseases
影响因子:20.6
doi:10.1136/annrheumdis-2020-219213
Westhovens, René; Rigby, William F C; van der Heijde, Désirée; Ching, Daniel W T; Stohl, William; Kay, Jonathan; Chopra, Arvind; Bartok, Beatrix; Matzkies, Franziska; Yin, Zhaoyu; Guo, Ying; Tasset, Chantal; Sundy, John S; Jahreis, Angelika; Mozaffarian, Neelufar; Messina, Osvaldo Daniel; Landewé, Robert Bm; Atsumi, Tatsuya; Burmester, Gerd R